89 related articles for article (PubMed ID: 35951627)
1. Pathophysiology and Nutritional Approaches in Polycystic Ovary Syndrome (PCOS): A Comprehensive Review.
Di Lorenzo M; Cacciapuoti N; Lonardo MS; Nasti G; Gautiero C; Belfiore A; Guida B; Chiurazzi M
Curr Nutr Rep; 2023 Sep; 12(3):527-544. PubMed ID: 37213054
[TBL] [Abstract][Full Text] [Related]
2. Are GLP-1R agonists the long-sought-after panacea for obesity?
Dowsett GKC; Yeo GSH
Trends Mol Med; 2023 Oct; 29(10):777-779. PubMed ID: 37460364
[TBL] [Abstract][Full Text] [Related]
3. The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome.
Anala AD; Saifudeen ISH; Ibrahim M; Nanda M; Naaz N; Atkin SL
J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510690
[TBL] [Abstract][Full Text] [Related]
4. Impact of GLP-1 Agonists on Male Reproductive Health-A Narrative Review.
Varnum AA; Pozzi E; Deebel NA; Evans A; Eid N; Sadeghi-Nejad H; Ramasamy R
Medicina (Kaunas); 2023 Dec; 60(1):. PubMed ID: 38256311
[No Abstract] [Full Text] [Related]
5. The impact of diabetes and obesity on fertility and the potential role of gut hormones as treatment.
Sridhar A; Khan D; Moffett RC
Diabet Med; 2023 Dec; 40(12):e15230. PubMed ID: 37734917
[TBL] [Abstract][Full Text] [Related]
6. Glucagon-like peptide 1 agonists: a ray of hope for the treatment of polycystic ovarian syndrome.
Babar A; Ali R; Zuhair V
J Pak Med Assoc; 2023 Dec; 73(12):2521-2522. PubMed ID: 38083956
[No Abstract] [Full Text] [Related]
7. Reproductive risk factors across the female lifecourse and later metabolic health.
Nichols AR; Chavarro JE; Oken E
Cell Metab; 2024 Feb; 36(2):240-262. PubMed ID: 38280383
[TBL] [Abstract][Full Text] [Related]
8. Hypogonadism and nonalcoholic fatty liver disease.
Papadimitriou K; Mousiolis AC; Mintziori G; Tarenidou C; Polyzos SA; Goulis DG
Endocrine; 2024 May; ():. PubMed ID: 38771482
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide-1 receptor agonists and safety in the preconception period.
Minis E; Stanford FC; Mahalingaiah S
Curr Opin Endocrinol Diabetes Obes; 2023 Dec; 30(6):273-279. PubMed ID: 37678163
[TBL] [Abstract][Full Text] [Related]
10. Multifaceted Roles of GLP-1 and Its Analogs: A Review on Molecular Mechanisms with a Cardiotherapeutic Perspective.
Pandey S; Mangmool S; Parichatikanond W
Pharmaceuticals (Basel); 2023 Jun; 16(6):. PubMed ID: 37375783
[TBL] [Abstract][Full Text] [Related]
11. GLP-1 receptor agonists, SGLT-2 inhibitors, and obstructive sleep apnoea: can new allies face an old enemy?
Papaetis GS
Arch Med Sci Atheroscler Dis; 2023; 8():e19-e34. PubMed ID: 37153372
[TBL] [Abstract][Full Text] [Related]
12. Liraglutide and polycystic ovary syndrome: is it only a matter of body weight?
Pugliese G; de Alteriis G; Muscogiuri G; Barrea L; Verde L; Zumbolo F; Colao A; Savastano S
J Endocrinol Invest; 2023 Sep; 46(9):1761-1774. PubMed ID: 37093453
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptide-1 receptor agonists decrease hyperinsulinemia and hyperandrogenemia in dehydroepiandrosterone-induced polycystic ovary syndrome mice and are associated with mitigating inflammation and inducing browning of white adipose tissue†.
Zhang Y; Lin Y; Li G; Yuan Y; Wang X; Li N; Xiong C; Yang Y; Ma Y; Zhang Z; Ding X
Biol Reprod; 2023 Jun; 108(6):945-959. PubMed ID: 36930063
[TBL] [Abstract][Full Text] [Related]
14. GLP-1 receptor agonists, polycystic ovary syndrome and reproductive dysfunction: Current research and future horizons.
Papaetis GS; Kyriacou A
Adv Clin Exp Med; 2022 Nov; 31(11):1265-1274. PubMed ID: 35951627
[TBL] [Abstract][Full Text] [Related]
15. The role of glucagon-like peptide-1 in reproduction: from physiology to therapeutic perspective.
Jensterle M; Janez A; Fliers E; DeVries JH; Vrtacnik-Bokal E; Siegelaar SE
Hum Reprod Update; 2019 Jul; 25(4):504-517. PubMed ID: 31260047
[TBL] [Abstract][Full Text] [Related]
16. Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists.
Cena H; Chiovato L; Nappi RE
J Clin Endocrinol Metab; 2020 Aug; 105(8):e2695-709. PubMed ID: 32442310
[TBL] [Abstract][Full Text] [Related]
17. A systematic review of GLP-1 on anthropometrics, metabolic and endocrine parameters in patients with PCOS.
Bader S; Bhatti R; Mussa B; Abusanana S
Womens Health (Lond); 2024; 20():17455057241234530. PubMed ID: 38444070
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
